|
Name |
[(1S,6R)-2,5-dioxo-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-7-oxabicyclo[4.1.0]hept-3-en-3-yl]methyl acetate
|
Molecular Formula | C24H32O5 | |
IUPAC Name* |
[(1S,6R)-2,5-dioxo-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-7-oxabicyclo[4.1.0]hept-3-en-3-yl]methyl acetate
|
|
SMILES |
CC(=CCC/C(=C/CC/C(=C/C[C@]12[C@H](O1)C(=O)C(=CC2=O)COC(=O)C)/C)/C)C
|
|
InChI |
InChI=1S/C24H32O5/c1-16(2)8-6-9-17(3)10-7-11-18(4)12-13-24-21(26)14-20(15-28-19(5)25)22(27)23(24)29-24/h8,10,12,14,23H,6-7,9,11,13,15H2,1-5H3/b17-10+,18-12+/t23-,24+/m1/s1
|
|
InChIKey |
ZNJXRPDYPGYTCI-QCZFUNBTSA-N
|
|
Synonyms |
Yanuthone B
|
|
CAS | NA | |
PubChem CID | 101089578 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 400.5 | ALogp: | 4.8 |
HBD: | 0 | HBA: | 5 |
Rotatable Bonds: | 11 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 73.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 29 | QED Weighted: | 0.292 |
Caco-2 Permeability: | -4.844 | MDCK Permeability: | 0.00002670 |
Pgp-inhibitor: | 0.919 | Pgp-substrate: | 0.065 |
Human Intestinal Absorption (HIA): | 0.048 | 20% Bioavailability (F20%): | 0.166 |
30% Bioavailability (F30%): | 0.251 |
Blood-Brain-Barrier Penetration (BBB): | 0.876 | Plasma Protein Binding (PPB): | 84.96% |
Volume Distribution (VD): | 0.864 | Fu: | 14.75% |
CYP1A2-inhibitor: | 0.049 | CYP1A2-substrate: | 0.072 |
CYP2C19-inhibitor: | 0.732 | CYP2C19-substrate: | 0.201 |
CYP2C9-inhibitor: | 0.663 | CYP2C9-substrate: | 0.102 |
CYP2D6-inhibitor: | 0.296 | CYP2D6-substrate: | 0.052 |
CYP3A4-inhibitor: | 0.632 | CYP3A4-substrate: | 0.288 |
Clearance (CL): | 5.114 | Half-life (T1/2): | 0.62 |
hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.872 |
Drug-inuced Liver Injury (DILI): | 0.559 | AMES Toxicity: | 0.922 |
Rat Oral Acute Toxicity: | 0.009 | Maximum Recommended Daily Dose: | 0.655 |
Skin Sensitization: | 0.966 | Carcinogencity: | 0.15 |
Eye Corrosion: | 0.042 | Eye Irritation: | 0.293 |
Respiratory Toxicity: | 0.487 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003714 | 0.743 | D09XWD | 0.440 | ||||
ENC001464 | 0.566 | D03VFL | 0.414 | ||||
ENC001465 | 0.512 | D05XQE | 0.404 | ||||
ENC001466 | 0.512 | D01ZUA | 0.248 | ||||
ENC001462 | 0.452 | D06BLQ | 0.213 | ||||
ENC001096 | 0.452 | D0X7XG | 0.203 | ||||
ENC006119 | 0.439 | D0OL7F | 0.202 | ||||
ENC001716 | 0.421 | D09SIK | 0.202 | ||||
ENC002413 | 0.419 | D0L2UN | 0.201 | ||||
ENC001717 | 0.419 | D04FBR | 0.194 |